Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Narrow Trijet Resonances in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.

Physical review letters·2024
Same author

Search for Baryon Number Violation in Top Quark Production and Decay Using Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Radiomics model and deep learning model based on T1WI image for acute lymphoblastic leukemia identification.

Clinical radiology·2024
Same author

Search for exotic decays of the Higgs boson to a pair of pseudoscalars in the <math></math> and <math></math> final states.

The European physical journal. C, Particles and fields·2024
Same author

[Overview of the ten global conferences on health promotion and implications for future work].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2024

Related Experiment Videos

Topiramate induced acute angle closure glaucoma.

A Aminlari1, M East, W Wei

  • 1Department of Ophthalmology, Pennsylvania State University Milton S. Hershey Medical Center, Hershey, USA. Aaminlari@psu.edu

The Open Ophthalmology Journal
|May 30, 2009
PubMed
Summary
This summary is machine-generated.

Topiramate, used for seizures and migraines, can cause bilateral angle closure glaucoma. This condition mimics acute glaucoma and requires prompt recognition, especially when affecting both eyes.

Related Experiment Videos

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Topiramate is an oral medication for seizure, migraine, and neuropathic pain.
  • It is known to cause secondary angle closure, mimicking acute angle closure glaucoma.

Purpose of the Study:

  • To report two cases of bilateral angle closure glaucoma secondary to topiramate.
  • To emphasize the importance of considering medication-induced angle closure in bilateral presentations.

Main Methods:

  • Case report of two patients presenting with bilateral angle closure.
  • Review of clinical presentation, diagnostic findings, and treatment outcomes.

Main Results:

  • Both patients developed bilateral angle closure glaucoma secondary to topiramate use.
  • The condition mimicked acute angle closure glaucoma.

Conclusions:

  • Bilateral angle closure glaucoma can be a secondary effect of topiramate.
  • High suspicion for topiramate-induced angle closure is warranted in bilateral cases.